Results 221 to 230 of about 57,977 (335)

Beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal clients to involuntary drug and alcohol treatment: A qualitative study

open access: yesDrug and Alcohol Review, Volume 42, Issue 1, Page 169-180, January 2023., 2023
Abstract Introduction Involuntary drug and alcohol treatment occurs in many countries and its role is often controversial. This can be a particular concern in relation to First Nations or other culturally distinct populations. This study explores beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal Australians to
K. S. Kylie Lee   +5 more
wiley   +1 more source

Alcohol and aging: Next‐generation epigenetic clocks predict biological age acceleration in individuals with alcohol use disorder

open access: yesAlcohol, Clinical and Experimental Research, EarlyView.
Our study investigated the performance of five epigenetic clocks by evaluating associations with alcohol use disorder (AUD) and various alcohol‐related phenotypes. Both DNAm GrimAge versions were associated with AUD and alcohol behaviors/clinical measures in the total sample and age subgroups.
Tyler A. Perlstein   +6 more
wiley   +1 more source

Publicly subsidised smoking cessation medicines in times of COVID‐19 in Australia: An interrupted time series analysis

open access: yesDrug and Alcohol Review, Volume 42, Issue 1, Page 225-232, January 2023., 2023
Abstract Introduction In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID‐19 pandemic that subsequently returned to expected levels. Smoking cessation medicines may not follow this pattern because quit attempts are influenced by a range of factors.
Dolly Baliunas   +5 more
wiley   +1 more source

Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology. [PDF]

open access: yesBrain Sci, 2020
Becchetti A   +4 more
europepmc   +1 more source

Blood phosphatidylethanol measurements indicate GLP‐1 receptor stimulation causes delayed decreases in alcohol consumption

open access: yesAlcohol, Clinical and Experimental Research, EarlyView.
Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) are effective for treating obesity (BMI ≥30) and are being investigated as a novel treatment for alcohol use disorder (AUD). This secondary analysis of a randomized clinical trial evaluated the effect of exenatide versus placebo on alcohol consumption using phosphatidylethanol (PEth) in 30 AUD ...
Mathias E. Jensen   +6 more
wiley   +1 more source

Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters. [PDF]

open access: yesACS Chem Neurosci
Williams BM   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy